Evidence map›Paper›PMID 36697839›Full record

ArticleCommunications chemistry2021

Two-photon activated precision molecular photosensitizer targeting mitochondria.

Inês F A Mariz, Sandra N Pinto, Ana M Santiago, José M G Martinho, Javier Recio, Juan J Vaquero, Ana M Cuadro, Ermelinda Maçôas

Open access · goldAbstract read
In one paragraph

Article in Communications chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Dilating the aging clock with light.Innovation (Cambridge (Mass.)) · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Inês F A MarizCentro de Química Estrutural (CQE) and Institute of Molecular Sciences (IMS), Instituto Superior Técnico, Universidade de Lisboa, 1049-001, Lisboa, Portugal.
Sandra N PintoInstitute for Bioengineering and Biosciences (IBB) Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001, Lisboa, Portugal.ORCID http://orcid.org/0000-0002-3205-9459
Ana M SantiagoCentro de Química Estrutural (CQE) and Institute of Molecular Sciences (IMS), Instituto Superior Técnico, Universidade de Lisboa, 1049-001, Lisboa, Portugal.
José M G MartinhoCentro de Química Estrutural (CQE) and Institute of Molecular Sciences (IMS), Instituto Superior Técnico, Universidade de Lisboa, 1049-001, Lisboa, Portugal.ORCID http://orcid.org/0000-0003-1806-1568
Javier RecioDepartamento de Química Orgánica y Química Inorgánica, Universidad de Alcalá, (IRYCIS), 28871-Alcalá de Henares, Madrid, Spain.ORCID http://orcid.org/0000-0003-0711-0977
Juan J VaqueroDepartamento de Química Orgánica y Química Inorgánica, Universidad de Alcalá, (IRYCIS), 28871-Alcalá de Henares, Madrid, Spain.
Ana M CuadroDepartamento de Química Orgánica y Química Inorgánica, Universidad de Alcalá, (IRYCIS), 28871-Alcalá de Henares, Madrid, Spain. ana.cuadro@uah.es.ORCID http://orcid.org/0000-0002-8077-6938
Ermelinda MaçôasCentro de Química Estrutural (CQE) and Institute of Molecular Sciences (IMS), Instituto Superior Técnico, Universidade de Lisboa, 1049-001, Lisboa, Portugal. ermelinda.macoas@tecnico.ulisboa.pt.ORCID http://orcid.org/0000-0001-8506-7025
University of Lisbon · PTUniversidad de Alcalá · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondria metabolism is an emergent target for the development of novel anticancer agents. It is amply recognized that strategies that allow for modulation of mitochondrial function in specific cell populations need to be developed for the therapeutic potential of mitochondria-targeting agents to become a reality in the clinic. In this work, we report dipolar and quadrupolar quinolizinium and benzimidazolium cations that show mitochondria targeting ability and localized light-induced mitochondria damage in live animal cells. Some of the dyes induce a very efficient disruption of mitochondrial potential and subsequent cell death under two-photon excitation in the Near-infrared (NIR) opening up possible applications of azonia/azolium aromatic heterocycles as precision photosensitizers. The dipolar compounds could be excited in the NIR due to a high two-photon brightness while exhibiting emission in the red part of the visible spectra (600-700 nm). Interaction with the mitochondria leads to an unexpected blue-shift of the emission of the far-red emitting compounds, which we assign to emission from the locally excited state. Interaction and possibly aggregation at the mitochondria prevents access to the intramolecular charge transfer state responsible for far-red emission.

Identifiers

PMID36697839
PMCPMC9814857
OpenAlexW3204371616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.